616 related articles for article (PubMed ID: 16541247)
1. 3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings.
Baumann MH; Wang X; Rothman RB
Psychopharmacology (Berl); 2007 Jan; 189(4):407-24. PubMed ID: 16541247
[TBL] [Abstract][Full Text] [Related]
2. A neurotoxic regimen of MDMA suppresses behavioral, thermal and neurochemical responses to subsequent MDMA administration.
Shankaran M; Gudelsky GA
Psychopharmacology (Berl); 1999 Nov; 147(1):66-72. PubMed ID: 10591870
[TBL] [Abstract][Full Text] [Related]
3. MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: implications for MDMA-induced neurotoxicity and treatment.
Verrico CD; Miller GM; Madras BK
Psychopharmacology (Berl); 2007 Jan; 189(4):489-503. PubMed ID: 16220332
[TBL] [Abstract][Full Text] [Related]
4. Neural and cardiac toxicities associated with 3,4-methylenedioxymethamphetamine (MDMA).
Baumann MH; Rothman RB
Int Rev Neurobiol; 2009; 88():257-96. PubMed ID: 19897081
[TBL] [Abstract][Full Text] [Related]
5. Vesicular monoamine transporter 2 and the acute and long-term response to 3,4-(±)-methylenedioxymethamphetamine.
Lizarraga LE; Cholanians AB; Phan AV; Herndon JM; Lau SS; Monks TJ
Toxicol Sci; 2015 Jan; 143(1):209-19. PubMed ID: 25370842
[TBL] [Abstract][Full Text] [Related]
6. Chronic stress enhances the corticosterone response and neurotoxicity to +3,4-methylenedioxymethamphetamine (MDMA): the role of ambient temperature.
Johnson BN; Yamamoto BK
J Pharmacol Exp Ther; 2010 Oct; 335(1):180-9. PubMed ID: 20634423
[TBL] [Abstract][Full Text] [Related]
7. The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").
Green AR; Mechan AO; Elliott JM; O'Shea E; Colado MI
Pharmacol Rev; 2003 Sep; 55(3):463-508. PubMed ID: 12869661
[TBL] [Abstract][Full Text] [Related]
8. Reinforcing effects of methylenedioxy amphetamine congeners in rhesus monkeys: are intravenous self-administration experiments relevant to MDMA neurotoxicity?
Fantegrossi WE
Psychopharmacology (Berl); 2007 Jan; 189(4):471-82. PubMed ID: 16555062
[TBL] [Abstract][Full Text] [Related]
9. On the role of tyrosine and peripheral metabolism in 3,4-methylenedioxymethamphetamine-induced serotonin neurotoxicity in rats.
Goñi-Allo B; Puerta E; Mathúna BO; Hervias I; Lasheras B; de la Torre R; Aguirre N
Neuropharmacology; 2008 Apr; 54(5):885-900. PubMed ID: 18329670
[TBL] [Abstract][Full Text] [Related]
10. (+/-)3,4-Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: clinical studies.
McCann UD; Eligulashvili V; Ricaurte GA
Neuropsychobiology; 2000; 42(1):11-6. PubMed ID: 10867551
[TBL] [Abstract][Full Text] [Related]
11. Ascorbic acid prevents 3,4-methylenedioxymethamphetamine (MDMA)-induced hydroxyl radical formation and the behavioral and neurochemical consequences of the depletion of brain 5-HT.
Shankaran M; Yamamoto BK; Gudelsky GA
Synapse; 2001 Apr; 40(1):55-64. PubMed ID: 11170222
[TBL] [Abstract][Full Text] [Related]
12. Ethanol, 3,4-methylenedioxymethamphetamine (ecstasy) and their combination: long-term behavioral, neurochemical and neuropharmacological effects in the rat.
Cassel JC; Riegert C; Rutz S; Koenig J; Rothmaier K; Cosquer B; Lazarus C; Birthelmer A; Jeltsch H; Jones BC; Jackisch R
Neuropsychopharmacology; 2005 Oct; 30(10):1870-82. PubMed ID: 15785779
[TBL] [Abstract][Full Text] [Related]
13. (+/-)3,4-Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: studies in animals.
Ricaurte GA; Yuan J; McCann UD
Neuropsychobiology; 2000; 42(1):5-10. PubMed ID: 10867550
[TBL] [Abstract][Full Text] [Related]
14. Serotonin reuptake transporter deficiency modulates the acute thermoregulatory and locomotor activity response to 3,4-(±)-methylenedioxymethamphetamine, and attenuates depletions in serotonin levels in SERT-KO rats.
Lizarraga LE; Phan AV; Cholanians AB; Herndon JM; Lau SS; Monks TJ
Toxicol Sci; 2014 Jun; 139(2):421-31. PubMed ID: 24595820
[TBL] [Abstract][Full Text] [Related]
15. Effects of intracerebroventricular administration of 5-(glutathion-S-yl)-alpha-methyldopamine on brain dopamine, serotonin, and norepinephrine concentrations in male Sprague-Dawley rats.
Miller RT; Lau SS; Monks TJ
Chem Res Toxicol; 1996 Mar; 9(2):457-65. PubMed ID: 8839050
[TBL] [Abstract][Full Text] [Related]
16. Tolerance to 3,4-methylenedioxymethamphetamine in rats exposed to single high-dose binges.
Baumann MH; Clark RD; Franken FH; Rutter JJ; Rothman RB
Neuroscience; 2008 Mar; 152(3):773-84. PubMed ID: 18313226
[TBL] [Abstract][Full Text] [Related]
17. Dissociation of the neurochemical and behavioral toxicology of MDMA ('Ecstasy') by citalopram.
Piper BJ; Fraiman JB; Owens CB; Ali SF; Meyer JS
Neuropsychopharmacology; 2008 Apr; 33(5):1192-205. PubMed ID: 17609680
[TBL] [Abstract][Full Text] [Related]
18. 3,4-Methylenedioxymethamphetamine induces monoamine release, but not toxicity, when administered centrally at a concentration occurring following a peripherally injected neurotoxic dose.
Esteban B; O'Shea E; Camarero J; Sanchez V; Green AR; Colado MI
Psychopharmacology (Berl); 2001 Mar; 154(3):251-60. PubMed ID: 11351932
[TBL] [Abstract][Full Text] [Related]
19. Long-term central 5-HT depletions resulting from repeated administration of MDMA enhances the effects of single administration of MDMA on schedule-controlled behavior of rats.
Li AA; Marek GJ; Vosmer G; Seiden LS
Pharmacol Biochem Behav; 1989 Jul; 33(3):641-8. PubMed ID: 2573905
[TBL] [Abstract][Full Text] [Related]
20. Behavioural, hyperthermic and neurotoxic effects of 3,4-methylenedioxymethamphetamine analogues in the Wistar rat.
O'Loinsigh ED; Boland G; Kelly JP; O'Boyle KM
Prog Neuropsychopharmacol Biol Psychiatry; 2001 Apr; 25(3):621-38. PubMed ID: 11371001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
